Search
Transmedics Group Inc
TMDXAdd to Watchlist
88.240USD
+19.260+27.92%
Close 11-06 16:00（ET）
3.06BMarket Cap
17.48P/E TTM
After-hours 18:56 (ET)87.700USD-0.530-0.60%
After-hours 18:56 (ET)Transmedics Group Inc (TMDX) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Transmedics Group Inc in the past month.
Buy
3 Strong Buy
5 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
103.455USD+56.77%
TMDX Analyst Recommendation Trends
In the current month, TMDX has received 5 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. TMDX average Analyst price target in the last month is 103.455.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
5
5
5
5
5
5
6
6
6
6
6
5
5
5
4
4
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
13
13
13
13
14
14
14
TMDX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, TMDX EPS is projected to reach 0.514 in FY2026Q4, following reported EPS of 0.492 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.61
0.47
0.29
0.51
0.47
Actual
0.21
0.42
0.49
--
--
Surprise
-65.28%
-10.30%
+68.60%
--
--
FAQs
What is Transmedics Group Inc's expected revenue for the next quarter?
Transmedics Group Inc's expected revenue is 201.47M.
What is Transmedics Group Inc's price target?
Analysts forecast that Transmedics Group Inc's price target is USD 103.91, with the highest forecast at USD 135.00 and the lowest forecast at USD 65.00.
How have Transmedics Group IncTMDX's recent earnings per share performed?
The market expectation was USD 0.49, while Transmedics Group IncTMDX's earnings per share (EPS) for the previous quarter was USD 0.42. EPS for the next quarter is expected at USD 0.51.
What is the analyst rating for Transmedics Group Inc?
Based on the ratings of Transmedics Group Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.